Entero Healthcare Solutions (NSE:ENTERO) Piotroski F-Score: 5 (As of Jun. 29, 2026) — Near Median


NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
43 GF Score
Price ₹1,200.10
! 2 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions Piotroski F-Score?

Entero Healthcare Solutions NSE:ENTERO +1.67% 43 Piotroski F-Score is 5 as of Jun. 29, 2026, which is at its 10-year median of 5.00. GuruFocus rates NSE:ENTERO with a GF Score™ of 43/100. The stock has 2 warning signs investors should review. Among 112 Medical Distribution companies, Entero Healthcare Solutions ranks better than 53.57% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Entero Healthcare Solutions has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Entero Healthcare Solutions's Piotroski F-Score or its related term are showing as below:

NSE:ENTERO' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 7
Current: 5

During the past 6 years, the highest Piotroski F-Score of Entero Healthcare Solutions was 7. The lowest was 3. And the median was 5.

Entero Healthcare Solutions  (NSE:ENTERO) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Entero Healthcare Solutions Piotroski F-Score Related Terms


Entero Healthcare Solutions Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions Piotroski F-Score Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial N/A 3.00 7.00 4.00 5.00

Entero Healthcare Solutions Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 0.00 0.00 0.00 5.00

NSE:ENTERO vs MCK, CAH, COR: Piotroski F-Score Comparison

For the Medical Distribution subindustry, Entero Healthcare Solutions's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entero Healthcare Solutions Piotroski F-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Entero Healthcare Solutions's Piotroski F-Score falls into.


NSE:ENTERO
43GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹1,150 Mil.
Cash Flow from Operations was ₹962 Mil.
Revenue was ₹65,912 Mil.
Gross Profit was ₹6,804 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (27025.15 + 36002.63) / 2 = ₹31513.89 Mil.
Total Assets at the begining of this year (Mar25) was ₹27,025 Mil.
Long-Term Debt & Capital Lease Obligation was ₹2,049 Mil.
Total Current Assets was ₹25,084 Mil.
Total Current Liabilities was ₹15,876 Mil.
Net Income was ₹948 Mil.

Revenue was ₹50,958 Mil.
Gross Profit was ₹4,863 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (23449.75 + 27025.15) / 2 = ₹25237.45 Mil.
Total Assets at the begining of last year (Mar24) was ₹23,450 Mil.
Long-Term Debt & Capital Lease Obligation was ₹670 Mil.
Total Current Assets was ₹20,757 Mil.
Total Current Liabilities was ₹8,450 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Entero Healthcare Solutions's current Net Income (TTM) was 1,150. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Entero Healthcare Solutions's current Cash Flow from Operations (TTM) was 962. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=1150.42/27025.15
=0.0425685

ROA (Last Year)=Net Income/Total Assets (Mar24)
=948.2/23449.75
=0.0404354

Entero Healthcare Solutions's return on assets of this year was 0.0425685. Entero Healthcare Solutions's return on assets of last year was 0.0404354. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Entero Healthcare Solutions's current Net Income (TTM) was 1,150. Entero Healthcare Solutions's current Cash Flow from Operations (TTM) was 962. ==> 962 <= 1,150 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=2049.39/31513.89
=0.06503132

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=670.18/25237.45
=0.02655498

Entero Healthcare Solutions's gearing of this year was 0.06503132. Entero Healthcare Solutions's gearing of last year was 0.02655498. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=25084.36/15875.7
=1.58004749

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=20757.09/8450.17
=2.45641094

Entero Healthcare Solutions's current ratio of this year was 1.58004749. Entero Healthcare Solutions's current ratio of last year was 2.45641094. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Entero Healthcare Solutions's number of shares in issue this year was 43.577. Entero Healthcare Solutions's number of shares in issue last year was 43.575. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=6803.82/65912.12
=0.10322563

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4863.06/50957.8
=0.09543308

Entero Healthcare Solutions's gross margin of this year was 0.10322563. Entero Healthcare Solutions's gross margin of last year was 0.09543308. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=65912.12/27025.15
=2.43891782

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=50957.8/23449.75
=2.17306368

Entero Healthcare Solutions's asset turnover of this year was 2.43891782. Entero Healthcare Solutions's asset turnover of last year was 2.17306368. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+0+0+0+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Entero Healthcare Solutions has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Entero Healthcare Solutions (NSE:ENTERO) has a Piotroski F-Score of 5 as of Jun. 29, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Entero Healthcare Solutions and its competitors. This is near median its historical median of 5.00. Over the past decade, Entero Healthcare Solutions' Piotroski F-Score has ranged from 3.00 to 7.00. According to the industry distribution chart, Entero Healthcare Solutions ranks #52 out of 112 companies in the Medical Distribution industry, placing it in the top 46.4%.
Is Entero Healthcare Solutions' Piotroski F-Score too high?
Entero Healthcare Solutions' current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 7.00. The Medical Distribution industry median Piotroski F-Score is 5.00. Entero Healthcare Solutions' value of 5 is 0% at this industry median. Based on the distribution chart, Entero Healthcare Solutions ranks #52 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Entero Healthcare Solutions has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Piotroski F-Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Entero Healthcare Solutions ranks #52 out of 112 companies for Piotroski F-Score. This puts Entero Healthcare Solutions in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Entero Healthcare Solutions' value of 5 is 0% at this benchmark. Historically, Entero Healthcare Solutions' own Piotroski F-Score has ranged from 3.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Entero Healthcare Solutions has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entero Healthcare Solutions's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Entero Healthcare Solutions and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entero Healthcare Solutions's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Entero Healthcare Solutions (NSE:ENTERO) has a current Piotroski F-Score of 5. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Medical Distribution industry median of 5.00. Entero Healthcare Solutions' overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Piotroski F-Score is 5 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
43GF Score

Get the complete analysis for NSE:ENTERO

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,200.10
Price